TRIB (TRIB) revenue breakdown
By product, Clinical laboratory goods is the largest at 72% of fiscal 2025 revenue; Point-of-Care grew fastest, -8% a year over 9 years.
By region, United States is the largest at 78% of fiscal 2025 revenue; Ireland grew fastest, -10% a year over 6 years.
Revenue by product
Fiscal years, as TRIB reports them in its 10-K filings; fiscal 2025 total $44M.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical laboratory goods | $74M | $73M | $72M | $68M | $84M | $63M | $46M | $42M | $39M | $32M | 72% |
| Point-of-Care | $17M | $17M | $15M | $11M | $9M | $10M | $9M | $9M | $17M | $8M | 19% |
| Clinical laboratory services | $9M | $9M | $11M | $11M | $8M | $8M | $7M | $5M | $5M | $4M | 9% |
Revenue by region
Fiscal years, as TRIB reports them in its 10-K filings; fiscal 2025 total $67M.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | — | — | — | $104M | $137M | $116M | $77M | $67M | $62M | $52M | 78% |
| Ireland | — | — | — | $28M | $25M | $16M | $13M | $13M | $20M | $15M | 22% |
| USA | $103M | — | — | — | — | — | — | — | — | — | — |
| Americas | — | $60M | $58M | — | — | — | — | — | — | — | — |
| Ireland | $41M | — | — | — | — | — | — | — | — | — | — |
| Asia / Africa | — | $27M | $29M | — | — | — | — | — | — | — | — |
| Europe (including Ireland) | — | $12M | $10M | — | — | — | — | — | — | — | — |
| Other Countries | $352,000 | — | — | — | — | — | — | — | — | — | — |
| Eliminations | -$45M | — | — | — | — | — | — | — | — | — | — |
| Eliminations | — | — | — | -$41M | -$60M | -$52M | -$27M | -$23M | -$21M | -$23M | -35% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for TRIB.
Open TRIB in InvestinglyQuestions
Where does TRIB make its money?
In fiscal 2025, by product: Clinical laboratory goods $32M, Point-of-Care $8M, Clinical laboratory services $4M.
From TRIB's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.